Most of us picture blood donation as simple: book an appointment, donate, have a biscuit, and your blood becomes someone else’s lifeline. But as Episode 13 of the Let’s Talk Health and Care podcast reveals, the reality is far more complex and far more fragile.
In The Fragile Lifeline: Rethinking How We Make and Move Blood, hosts Marc Griffiths and Peter Brindle are joined by Professor Wendy Phillips and Dr Helen Sanderson to explore a question that sits at the heart of healthcare resilience:
What if the future of blood supply isn’t about bigger donations but smarter manufacturing?
Why the blood supply chain is more vulnerable than we realise
Wendy and Helen unpack the hidden complexity behind every blood transfusion. Blood isn’t a single product: it’s separated into components, tested, tracked, and cross-matched with rigorous checkpoints at every stage. And because blood products are highly temperature-sensitive, even a small break in the “cold chain” can mean it becomes unusable.
The episode also highlights how disruption can ripple quickly across the system. From seasonal drops in donor numbers to extreme heat impacting storage conditions, the supply chain is under constant pressure. Wendy points to the seriousness of these risks by referencing an incident where a cyberattack on a third-party supplier had significant knock-on impacts, contributing to shortages and raising concerns about how close the system can come to critical levels.
The message is clear: blood supply is a lifeline but it’s a lifeline with weak points.
Making blood closer to where it’s needed
The conversation then shifts to the future: redistributed manufacturing – producing critical healthcare products closer to the point of need, at the scale required, when they’re required.
Dr Sanderson draws on work with defence partners to explain the logistical reality: blood products often need frequent resupply, have short shelf lives, and rely on refrigerated storage which can lead to waste even as teams must stay prepared for worst-case scenarios.
The innovation isn’t only about the blood itself, either. The episode surfaces a key (often overlooked) point: packaging is part of resilience. If essential medical packaging is sourced from a single nation or relies on fragile materials like glass, that’s another pressure point in an already delicate system.
What innovations are on the horizon?
This episode offers a genuinely fascinating glimpse of what “next” could look like and what might arrive sooner than people expect.
Among the approaches discussed:
- Spray-dried plasma, currently being tested and scaled, as a more resilient alternative manufacturing route
- “Walking blood banks” in deployed settings, which could provide rapid access to blood, though regulatory and ethical considerations remain
- Freeze-dried components, which could reduce reliance on cold storage and simplify transport
- Lab-grown red blood cells, still some way off at scale, but increasingly promising for targeted use (such as rare blood disorders)
- Steps toward more universal blood, reducing inequalities caused by shortages in blood types needed by specific communities
Importantly, Wendy and Helen emphasise that innovation isn’t just “high-tech science” – it also requires the right systems around it: reliable power, robust equipment, consistent standards, workable regulation, and a skilled workforce.
UWE Bristol’s role: connecting research, regulation and real-world impact
What stands out is how strongly this work reflects UWE Bristol’s strengths: research that crosses disciplines, responds to real-world challenges, and actively shapes practice.
Wendy discusses how the Redistributed Manufacturing in Healthcare network, originally launched before COVID-19, gained new urgency as the pandemic exposed how quickly global supply chains can fail and how vital it is to secure access to critical health products. The team’s work has contributed to shaping thinking in the regulatory space around point-of-care and decentralised manufacturing – an essential step in turning innovation into safe, usable healthcare solutions.
The episode also highlights the role of workforce development, including the way universities and industry partners can collaborate to build the skills needed for future healthcare manufacturing and supply.
Listen now
If you’re interested in the future of healthcare resilience or you’ve ever wondered what really happens after a donation – this episode is worth your time.
The Fragile Lifeline: Reinventing How We Make and Move Blood is available now as part of the Let’s Talk Health and Care podcast series from the Integrated Care Academy at UWE Bristol.